Results 31 to 40 of about 69,782 (261)
New and emerging therapeutic options for malignant pleural mesothelioma: review of early clinical trials. [PDF]
, 2015 Malignant pleural mesothelioma (MPM) is a rare tumor that is challenging to control. Despite some benefit from using the multimodality-approach (surgery, combination chemotherapy and radiation), survival remains poor. However, current research produced a
Cameron, Robert B +2 more
core +2 more sources
Breast cancer or metastasis? An unusual case of metastatic malignant pleural mesothelioma to the breast [PDF]
, 2015 Background: Metastases to the breast from extramammary malignancies are very rare, and ruling out the diagnosis of primary breast tumor is important in order to decide on clinical management and predict prognosis.
Derme, Martina +5 more
core +2 more sources
CT in differential diagnosis of benign and malignant pleural disease
Monaldi Archives for Chest Disease, 2005 Background. CT plays a valuable role in assessment of patients with a wide variety of diseases of the pleura, and pulmonologists should be aware of the significance of different CT findings for the differential diagnosis of benign and malignant pleural ...
U. Yilmaz +4 more
doaj +1 more source
Pathologic diagnosis of malignant mesothelioma: chronological prospect and advent of recommendations and guidelines [PDF]
, 2015 Malignant mesothelioma is rare and difficult to diagnose. Its identification depends upon pathological investigation (cyto-histological assessment and immunohistochemistry) supported by clinical and radiological evidence.
Ascoli, Valeria
core +2 more sources
Malignant pleural mesothelioma
Annals of Oncology, 2006 Malignant pleural mesothelioma G. L. Ceresoli, G. P. Betta, B. Castagneto, F. Facciolo, G. Arcangeli, P. A. Zucali, R. Libener, D. De Giovanni, E. Melis & M. A. Mirri Department of Medical Oncology and Hematology, Istituto Clinico Humanitas IRCCS, Rozzano (MI); Pathology Unit, Department of Oncology, Azienda Sanitaria Ospedaliera, Alessandria ...
G L, Ceresoli +9 more
openaire +2 more sources
Integrative Molecular Characterization of Malignant Pleural Mesothelioma.
Cancer Discovery, 2018 Malignant pleural mesothelioma (MPM) is a highly lethal cancer of the lining of the chest cavity. To expand our understanding of MPM, we conducted a comprehensive integrated genomic study, including the most detailed analysis of BAP1 alterations to date.
M. Ladanyi +142 more
semanticscholar +1 more source
Malignant pleural mesothelioma [PDF]
European Respiratory Journal, 1999 Malignant mesothelioma (MM) has recently attracted the attention of the media because of its relationship with professional and environmental exposure to asbestos. This tumour of the pleura is a disease which has emerged in significant numbers of patients during the last 30 years in the industrialized countries, and its increasing incidence makes it of
H Schouwink +3 more
openaire +3 more sources
Egyptian Journal of Chest Disease and Tuberculosis, 2013 Purpose: In malignant pleural mesothelioma (MPM), early assessment of disease status is important. We evaluated the role of mesothelin and osteopontin biomarkers in distinguishing MPM from benign pleural disease. We also, evaluated whether mesothelin and
Fawzy M. Amany +6 more
doaj +1 more source
Multiplex Soluble Biomarker Analysis from Pleural Effusion
Biomolecules, 2020 Malignant pleural mesothelioma (MPM) is a highly aggressive and therapy resistant pleural malignancy that is caused by asbestos exposure. MPM is associated with poor prognosis and a short patient survival.
Joman Javadi +2 more
doaj +1 more source
The role of immunohistochemical evaluation in the diagnosis of malignant mesothelioma of the pleura [PDF]
Vojnosanitetski Pregled, 2013 Backround/Aim. The final diagnosis of malignant pleural mesothelioma is made exclusively by histopathological examination of biopsy materials that are routinely complemented by the use of immunohistochemical analysis.
Panjković Milana +5 more
doaj +1 more source